{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:17:58Z","timestamp":1790489878631,"version":"4.1.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Macrophages are essential components of the human host immune system, which upon activation facilitates a broad pallet of immunomodulatory events including release of pro- or anti-inflammatory cytokines and chemokines, restoration of immune homeostasis and\/or wound healing. Moreover, some macrophage phenotypes are crucially involved in fibrogenesis through stimulation of myofibroblasts, while others promote fibrolysis. During the last decades, the role of resident liver macrophages viz. Kupffer cells and recruited monocytes\/macrophages in acute and chronic liver diseases has gained interest and been extensively investigated. Specifically, the scavenger receptors CD163 and mannose receptor (CD206), expressed by macrophages, are of utmost interest since activation by various stimuli induce their shedding to the circulation. Thus, quantifying concentrations of these soluble biomarkers may be of promising clinical relevance in estimating the severity of inflammation and fibrosis and to predict outcomes such as survival. Here, we review the existing literature on soluble CD163 and soluble mannose receptor in liver diseases with a particular focus on their relationship to hepatic fibrosis in metabolic associated fatty liver disease, as well as in chronic hepatitis B and C.<\/jats:p>","DOI":"10.3389\/fmed.2020.615599","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T06:17:55Z","timestamp":1610086675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Rasmus Hvidbjerg","family":"Gantzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Breinholt","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea Lund","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Kazankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger Jon","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","article-title":"All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study","volume":"32","author":"Fleming","year":"2012","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00424-017-1945-7","article-title":"Physiological roles of macrophages","volume":"469","author":"Gordon","year":"2017","journal-title":"Pflugers Arch"},{"key":"B7","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: an asset for the resolution of inflammation","volume":"142","author":"Porcheray","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/ng.3836","article-title":"IFN-\u03bb3, not IFN-\u03bb4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis","volume":"49","author":"Eslam","year":"2017","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"108445","DOI":"10.1016\/j.abb.2020.108445","article-title":"Liver fibrogenesis: un update on established and emerging basic concepts","volume":"689","author":"Novo","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"B19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario","volume":"29","author":"Parola","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/cells9051175","article-title":"Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure","volume":"9","author":"Nielsen","year":"2020","journal-title":"Cells"},{"key":"B23","first-page":"588","article-title":"A monocyte\/macrophage antigen recognized by the four antibodies GHI\/61, Ber-MAC3, Ki-M8 and SM4","volume":"75","author":"Pulford","year":"1992","journal-title":"Immunology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/jcp.44.11.936","article-title":"Ber-MAC3: new monoclonal antibody that defines human monocyte\/macrophage differentiation antigen","volume":"44","author":"Backe","year":"1991","journal-title":"J Clin Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"Moller","year":"2002","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1189\/jlb.1205756","article-title":"Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163","volume":"80","author":"Weaver","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/JLB.3A1218-500R","article-title":"The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms","volume":"106","author":"Nielsen","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EC-17-0296","article-title":"Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial","volume":"7","author":"Rittig","year":"2018","journal-title":"Endocr Connect"},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/jdi.12869","article-title":"Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis","volume":"10","author":"Svart","year":"2019","journal-title":"J Diabetes Investig"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.4049\/jimmunol.165.10.5428","article-title":"Dermal microvascular endothelial cells express the 180-kDa macrophage mannose receptor in situ and in vitro","volume":"165","author":"Groger","year":"2000","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1189\/jlb.0512231","article-title":"The mannose receptor","volume":"92","author":"Martinez-Pomares","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S1286-4579(00)01283-1","article-title":"Pneumocystis carinii enhances soluble mannose receptor production by macrophages","volume":"2","author":"Fraser","year":"2000","journal-title":"Microbes Infect"},{"key":"B34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1515\/cclm-2013-0451","article-title":"A soluble form of the macrophage-related mannose receptor (MR\/CD206) is present in human serum and elevated in critical illness","volume":"52","author":"Rodgaard-Hansen","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.07.045","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.jhep.2020.07.033","article-title":"Macrophage markers and innate immunity in cirrhosis","volume":"73","author":"Gr\u00f8nb\u00e6k","year":"2020","journal-title":"J Hepatol."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-7742-2_40-1","article-title":"Soluble CD163 (sCD163): biomarker of kupffer cell activation in liver disease","volume-title":"Biomarkers in Liver Disease","author":"M\u00f8ller","year":"2016"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/jgh.12943","article-title":"Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery","volume":"30","author":"Kazankov","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.27129","article-title":"Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C","volume":"60","author":"Kazankov","year":"2014","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13023-018-0910-7","article-title":"High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study","volume":"13","author":"Bj\u00f6rklund","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13023-020-01452-2","article-title":"The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease","volume":"15","author":"Glavind","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/liv.14466","article-title":"Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis","volume":"40","author":"Bossen","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/liv.13150","article-title":"The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease","volume":"36","author":"Kazankov","year":"2016","journal-title":"Liver Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/ctg.2015.36","article-title":"Circulating soluble CD163 is associated with steatohepatitis and advanced fibrosis in nonalcoholic fatty liver disease","volume":"6","author":"Mueller","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jvh.12309","article-title":"Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus","volume":"22","author":"Dultz","year":"2015","journal-title":"J Viral Hepat"},{"key":"B47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/jvh.12488","article-title":"The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients","volume":"23","author":"Dultz","year":"2016","journal-title":"J Viral Hepat"},{"key":"B48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/ijpo.252","article-title":"The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children","volume":"10","author":"Kazankov","year":"2015","journal-title":"Pediatr Obes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/00365513.2017.1346823","article-title":"Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease","volume":"77","author":"Rodgaard-Hansen","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/00365521.2018.1481996","article-title":"Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology","volume":"53","author":"Lund Laursen","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jgh.13849","article-title":"Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment","volume":"33","author":"Laursen","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/gutjnl-2012-304135","article-title":"Hepatic macrophage activation predicts clinical decompensation in chronic liver disease","volume":"62","author":"Rode","year":"2013","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2036.2012.05134.x","article-title":"Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis","volume":"36","author":"Gronbaek","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/apt.13618","article-title":"The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis","volume":"43","author":"Sandahl","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2013.01.005","article-title":"Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis","volume":"58","author":"Waidmann","year":"2013","journal-title":"J Hepatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/apt.14474","article-title":"Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation","volume":"47","author":"Rainer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jhep.2013.06.008","article-title":"Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma","volume":"59","author":"Waidmann","year":"2013","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/00365513.2015.1099722","article-title":"Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma","volume":"76","author":"Kazankov","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"B59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.prp.2004.10.006","article-title":"Expression of CD163 in the liver of patients with viral hepatitis","volume":"201","author":"Hiraoka","year":"2005","journal-title":"Pathol Res Pract"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/ajg.2014.262","article-title":"Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study","volume":"109","author":"Sandahl","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/hep.30617","article-title":"Biomarkers of macrophage activation and immune danger signals predict clinical outcomes in alcoholic hepatitis","volume":"70","author":"Saha","year":"2019","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"Moller","year":"2007","journal-title":"J Hepatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00535-004-1493-8","article-title":"Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure","volume":"40","author":"Hiraoka","year":"2005","journal-title":"J Gastroenterol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Gr\u00f8nb","year":"2016","journal-title":"J Hepatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MPG.0000000000002111","article-title":"Macrophage markers are poorly associated with liver histology in children with nonalcoholic fatty liver disease","volume":"67","author":"Kazankov","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10096-013-1936-3","article-title":"Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study","volume":"33","author":"Andersen","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/jvh.13204","article-title":"Time-dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C","volume":"27","author":"Laursen","year":"2020","journal-title":"J Viral Hepat"},{"key":"B68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/00365521.2019.1608292","article-title":"Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose","volume":"54","author":"Siggaard","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0189345","DOI":"10.1371\/journal.pone.0189345","article-title":"The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients","volume":"12","author":"Sandahl","year":"2017","journal-title":"PLoS ONE"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15125.","article-title":"Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation","author":"Gr\u00f8nbaek","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin Liver Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J Hepatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B78","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"B79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1741-7015-7-21","article-title":"The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease","volume":"7","author":"Nobili","year":"2009","journal-title":"BMC Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2013natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N Engl J Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1743-422X-8-161","article-title":"An overview of HCV molecular biology, replication and immune responses","volume":"8","author":"Ashfaq","year":"2011","journal-title":"Virol J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of Kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"J Hepatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1128\/JVI.00996-08","article-title":"Macrophages in hepatitis B and hepatitis C virus infections","volume":"83","author":"Heydtmann","year":"2009","journal-title":"J Virol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"12757","DOI":"10.1038\/ncomms12757","article-title":"MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C","volume":"7","author":"Thabet","year":"2016","journal-title":"Nat Commun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"Moller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10067-012-1972-x","article-title":"Increased serum levels of soluble CD163 in patients with scleroderma","volume":"31","author":"Shimizu","year":"2012","journal-title":"Clin Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/membranes5020228","article-title":"Drug trafficking into macrophages via the endocytotic receptor CD163","volume":"5","author":"Graversen","year":"2015","journal-title":"Membranes (Basel)."},{"key":"B88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.omtm.2016.11.004","article-title":"Antibody-directed glucocorticoid targeting to CD163 in M2-type macrophages attenuates fructose-induced liver inflammatory changes","volume":"4","author":"Svendsen","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1097\/CCM.0b013e31828a45ef","article-title":"Targeting dexamethasone to macrophages in a porcine endotoxemic model","volume":"41","author":"Granfeldt","year":"2013","journal-title":"Crit Care Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"CD163 and inflammation: biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid Redox Signal"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.615599\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T06:17:59Z","timestamp":1610086679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.615599\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":90,"alternative-id":["10.3389\/fmed.2020.615599"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.615599","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"article-number":"615599"}}